Pfizer Price Target Announced at $32.00/Share by Bernstein
Pfizer Analyst Ratings
Pfizer Initiated With a Market Perform at Bernstein
Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33
Morgan Stanley Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $30
Jefferies Sticks to Its Buy Rating for Pfizer (PFE)
Pfizer's Leadership Stability and Activist Investor Watch: A Hold Rating Analysis
Guggenheim Adjusts Pfizer Price Target to $36 From $35, Maintains Buy Rating
CFRA Initiates Pfizer(PFE.US) With Hold Rating, Announces Target Price $31
TD Cowen Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32
Wells Fargo Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $30
Pfizer Hold Rating: Balancing Valuation Concerns and Growth Challenges
J.P. Morgan Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $30
BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $36
Pfizer (PFE) Gets a Hold From J.P. Morgan
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Biogen (BIIB)
Barclays Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32
BMO Capital Adjusts Pfizer Price Target to $70 From $36
Pfizer Analyst Ratings
Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Cuts Target Price to $33